Related references
Note: Only part of the references are listed.Reduced Expression of IRF7 in Nasal Epithelial Cells from Smokers after Infection with Influenza
Ilona Jaspers et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae
Masaki Yamashita et al.
CANCER SCIENCE (2010)
Identification of Novel Methylation Markers in Hepatocellular Carcinoma using a Methylation Array
So Hyun Shin et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Oncolytic Viruses Move Forward in Clinical Trials
Karen Rowan
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
Han Hsi Wong et al.
VIRUSES-BASEL (2010)
Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma
Chang Do Jee et al.
EUROPEAN JOURNAL OF CANCER (2009)
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Shruthi Naik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells
Takashi Kumagai et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
Dmitriy Zamarin et al.
MOLECULAR THERAPY (2009)
Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts
Qunfang Li et al.
MOLECULAR CANCER RESEARCH (2008)
Impaired IFN-α production and the risk of cancer development
Kazuko Uno et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells
Guido Wollmann et al.
JOURNAL OF VIROLOGY (2007)
An optimized clinical regimen for the oncolytic virus PV701
Sebastien J. Hotte et al.
CLINICAL CANCER RESEARCH (2007)
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
Beihua Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Expression profiling identifies three pathways altered in cellular immortalization: Interferon, cell cycle, and cytoskeleton
Aviva Levine Fridman et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
Microarray analysis of promoter methylation in lung cancers
M Fukasawa et al.
JOURNAL OF HUMAN GENETICS (2006)
Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection
BJ Barnes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants
T Muster et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis
J Yu et al.
CELL RESEARCH (2003)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
M Obuchi et al.
JOURNAL OF VIROLOGY (2003)
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
OI Kulaeva et al.
ONCOGENE (2003)
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
AL Pecora et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Enhanced tumor development in mice lacking a functional type I interferon receptor
S Picaud et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease
M Fernandez et al.
JOURNAL OF VIROLOGY (2002)
De novo methylation of an embryonic globin gene during normal development is strand specific and spreads from the proximal transcribed region
R Singal et al.
BLOOD (2001)
Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis
S Balachandran et al.
JOURNAL OF VIROLOGY (2001)
IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7
J Sancéau et al.
ONCOGENE (2000)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Share Paper
